Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population

OBJECTIVES: Autoantibodies against apolipoprotein A1 (anti‐apoA1 IgGs) and its C‐terminal region (cter apoA1) have emerged as an independent biomarker for cardiovascular disease. Cter apoA1 mimetic peptides were shown to reverse the deleterious anti‐apoA1 IgG effects in vitro. We evaluated the assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuilleumier, Nicolas, Antiochos, Panagiotis, Marques‐Vidal, Pedro, Pagano, Sabrina, Virzi, Julien, Satta, Nathalie, Hartley, Oliver, Gaertner, Hubert, Brandt, Karim J, Burger, Fabienne, Montecucco, Fabrizio, Waeber, Gerard, Mach, François, Vollenweider, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734471/
https://www.ncbi.nlm.nih.gov/pubmed/33343896
http://dx.doi.org/10.1002/cti2.1220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734471/
https://www.ncbi.nlm.nih.gov/pubmed/33343896
http://dx.doi.org/10.1002/cti2.1220

Ejemplares similares